Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GE HealthCare Technologies (GEHC) Other financing activities (2022 - 2026)

GE HealthCare Technologies filings provide 5 years of Other financing activities readings, the most recent being -$2.0 million for Q1 2026.

  • On a quarterly basis, Other financing activities rose 66.67% to -$2.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$77.0 million, a 63.83% decrease, with the full-year FY2025 number at -$81.0 million, down 138.24% from a year prior.
  • Other financing activities hit -$2.0 million in Q1 2026 for GE HealthCare Technologies, up from -$25.0 million in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $7.0 million in Q1 2024 to a low of -$41.0 million in Q3 2025.
  • Median Other financing activities over the past 5 years was -$11.0 million (2024), compared with a mean of -$15.2 million.
  • Biggest five-year swings in Other financing activities: soared 116.67% in 2023 and later crashed 1200.0% in 2024.
  • GE HealthCare Technologies' Other financing activities stood at -$3.0 million in 2022, then crashed by 733.33% to -$25.0 million in 2023, then surged by 76.0% to -$6.0 million in 2024, then crashed by 316.67% to -$25.0 million in 2025, then skyrocketed by 92.0% to -$2.0 million in 2026.
  • The last three reported values for Other financing activities were -$2.0 million (Q1 2026), -$25.0 million (Q4 2025), and -$41.0 million (Q3 2025) per Business Quant data.